Schizophrenia and schizoaffective disorder treated with high doses of olanzapine

被引：20

作者：

Fanous, A ^{[1
]}

Lindenmayer, JP ^{[1
]}

机构：

[1] NYU, Sch Med, New York, NY 10016 USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 03期

关键词：

D O I：

10.1097/00004714-199906000-00015

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：275 / 276

页数：2

共 6 条

[1]

[Anonymous], 1986, POSITIVE NEGATIVE SY

[2] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].

Beasley, CM ;

Tollefson, G ;

Tran, P ;

Satterlee, W ;

Sanger, T ;

Hamilton, S ;

Fabre, L ;

Small, J ;

Ereshefsky, L ;

True, J ;

Nemeroff, C ;

Risch, SC ;

Perry, PJ ;

Potkin, SG ;

Borison, RL ;

James, S ;

Meltzer, HY ;

Iqbal, N ;

Fann, WE ;

Gewirtz, GR ;

Landbloom, R ;

RoyByrne, PP ;

Tuason, VB ;

Carman, JS ;

Stokes, PE ;

Williams, R ;

Ancill, RJ ;

MacEwan, GW ;

Gujavarty, KS ;

Jones, B ;

Lohr, JB .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123

[3]

Ereshefsky L, 1996, J CLIN PSYCHIAT, V57, P12

[4]

Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11

[5]

Tollefson GD, 1997, AM J PSYCHIAT, V154, P457

[6]

ZIPURSKY RB, 1997, AM COLL NEUR 36 ANN

← 1 →